Key Metrics
CiteScore 

2.5
SJR 

Q2Health Policy

SNIP 

0.74
Recommended pre-submission checks
Powered by 

Topics Covered on ClinicoEconomics and Outcomes Research
ClinicoEconomics and Outcomes Research Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2390 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in ClinicoEconomics and Outcomes Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in ClinicoEconomics and Outcomes Research
Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy
- 9 May 2026
- ClinicoEconomics and Outcomes Research: CEOR
Research Gaps and Priorities for aHUS in the Gulf Cooperation Countries (GCC): Findings from a Payer-Focused Expert Meeting.
- 1 May 2026
- ClinicoEconomics and outcomes research : CEOR
Cost-Effectiveness of Bivalent Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Italy
- 9 Apr 2026
- ClinicoEconomics and Outcomes Research: CEOR
Cost Minimization and Cost Comparison of the Use of Conventional Double Lumen Tube versus Single-Use VivaSight-Double Lumen Tube in Thoracic Surgery: The Pascale Institute Experience
- 3 Apr 2026
- ClinicoEconomics and Outcomes Research: CEOR
Real-World Progression-Free Survival and Healthcare Resource Utilization Associated with Daratumumab Use in Transplant-Ineligible Multiple Myeloma Patients in Italy
- 1 Apr 2026
- ClinicoEconomics and Outcomes Research: CEOR
Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosa.
- 1 Apr 2026
- ClinicoEconomics and outcomes research : CEOR
Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy
- 9 May 2026
- ClinicoEconomics and Outcomes Research: CEOR
Research Gaps and Priorities for aHUS in the Gulf Cooperation Countries (GCC): Findings from a Payer-Focused Expert Meeting.
- 1 May 2026
- ClinicoEconomics and outcomes research : CEOR
Cost-Effectiveness of Bivalent Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Italy
- 9 Apr 2026
- ClinicoEconomics and Outcomes Research: CEOR
Cost Minimization and Cost Comparison of the Use of Conventional Double Lumen Tube versus Single-Use VivaSight-Double Lumen Tube in Thoracic Surgery: The Pascale Institute Experience
- 3 Apr 2026
- ClinicoEconomics and Outcomes Research: CEOR
Real-World Progression-Free Survival and Healthcare Resource Utilization Associated with Daratumumab Use in Transplant-Ineligible Multiple Myeloma Patients in Italy
- 1 Apr 2026
- ClinicoEconomics and Outcomes Research: CEOR
Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosa.
- 1 Apr 2026
- ClinicoEconomics and outcomes research : CEOR